Hollencrest Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.12K | Hold |
16
| – | – | ﹤0.01% | 797 |
|
|
2025
Q1 | $7.76K | Sell |
16
-179
| -92% | -$86.8K | ﹤0.01% | 784 |
|
|
2024
Q4 | $78.5K | Sell |
195
-100
| -34% | -$40.3K | ﹤0.01% | 425 |
|
|
2024
Q3 | $137K | Hold |
295
| – | – | 0.01% | 326 |
|
|
2024
Q2 | $138K | Buy |
295
+100
| +51% | +$46.9K | 0.01% | 319 |
|
|
2024
Q1 | $81.5K | Sell |
195
-957
| -83% | -$400K | ﹤0.01% | 398 |
|
|
2023
Q4 | $469K | Buy |
1,152
+179
| +18% | +$72.8K | 0.04% | 201 |
|
|
2023
Q3 | $338K | Hold |
973
| – | – | 0.04% | 215 |
|
|
2023
Q2 | $342K | Hold |
973
| – | – | 0.04% | 223 |
|
|
2023
Q1 | $307K | Buy |
973
+957
| +5,981% | +$302K | 0.03% | 228 |
|
|
2022
Q4 | $4.62K | Buy |
+16
| New | +$4.62K | ﹤0.01% | 838 |
|